Evidence map›Paper›PMID 22964392›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2012

Subcellular trafficking and transfection efficacy of polyethylenimine-polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1.

Mikhail O Durymanov, Elena A Beletkaia, Alexey V Ulasov, Yuri V Khramtsov, Georgiy A Trusov, Nikita S Rodichenko, Tatiana A Slastnikova, Tatiana V Vinogradova, Natalia Y Uspenskaya, Eugene P Kopantsev and 3 more

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Gene delivery nanoparticles to modulate angiogenesis.Advanced drug delivery reviews · 2017
    Review
  8. Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Malignant melanoma and melanocortin 1 receptor.Biochemistry. Biokhimiia · 2013
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Mikhail O DurymanovDepartment of Molecular Genetics of Intracellular Transport, Institute of Gene Biology, Russian Academy of Sciences, 34/5, Vavilov St., 119334, Moscow, Russia. mdurymanov@gmail.com
Elena A Beletkaia
Alexey V Ulasov
Yuri V Khramtsov
Georgiy A Trusov
Nikita S Rodichenko
Tatiana A Slastnikova
Tatiana V Vinogradova
Natalia Y Uspenskaya
Eugene P Kopantsev
Andrey A Rosenkranz
Eugene D Sverdlov
Alexander S Sobolev
Institute of Gene Biology · RUInstitute of Bioorganic Chemistry · RULomonosov Moscow State University · RU

Funding

TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMAP50NS020023 · NINDS · DUKE UNIVERSITY · PI BIGNER, DARELL D · 1985 to 2013
$17.3M
NINDS NIH HHS P50 NS020023NINDS NIH HHS P50 NS20023
6 · The paper itself

Abstract

We have synthesized and investigated properties of new PEI-PEG-based polyplexes containing MC1SP-peptide, a ligand specific for melanocortin receptor-1 (targeted polyplexes), and control polyplexes without this ligand peptide (non-targeted polyplexes). The targeted polyplexes demonstrated receptor-mediated transfection of Cloudman S91 (clone M-3) murine melanoma cells that was more efficient than with the non-targeted ones. Transfection with the targeted polyplexes was inhibited by chlorpromazine, an inhibitor of the clathrin-mediated endocytosis pathway, and, to a lesser extent, by filipin III or nystatin, inhibitors of the lipid-raft endocytosis pathway, whereas transfection with the non-targeted polyplexes was inhibited mainly by nystatin or filipin III. The targeted polyplexes caused significantly higher in vivo transfection of melanoma tumor cells after intratumoral administration compared to the non-targeted control. The targeted polyplexes carrying the HSVtk gene, after ganciclovir administration, more efficiently inhibited melanoma tumor growth and prolonged the lifespan of DBA/2 tumor-bearing mice compared to the non-targeted ones. Packed targeted polyplexes appeared and accumulated in the melanoma cells 6h earlier than the non-targeted ones. The targeted polyplexes enter into the nuclei of the melanoma cells more rapidly than the non-targeted control, and this difference may also be attributed to processes of receptor-mediated endocytosis. We believe that these data may be useful for the optimization of polyplex systems.

Indexed as

AnimalsCell Line, TumorDNAEndocytosisGenes, erbB-1Genetic TherapyHEK293 CellsHumansLigandsLuciferases, FireflyMelanomaMiceMice, Inbred DBANanoparticlesOligopeptidesPolyethylene GlycolsDNALigandsLuciferases, FireflyOligopeptidespoly(ethylene glycol)-co-poly(ethyleneimine)Polyethylene GlycolsPolyethyleneimineReceptor, Melanocortin, Type 1

Identifiers

PMID22964392
PMCPMC3478489
OpenAlexW2033944362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.